Business
Twist Bioscience Now ISO 27001:2013 Certified for Information Security Management System
SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of
About this update from Twist Bioscience Corporation
[{"type":"text","content":" SAN FRANCISCO, Calif.--(BUSINESS WIRE)--\nTwist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has received ISO 27001:2013 certification for its Information Security Management System (ISMS).\n\n\nISO 27001:2013 is an information security standard published by the International Organization for Standardization (ISO), the world’s largest developer of voluntary international standards, and the International Electrotechnical Commission (IEC). Twist Bioscience’s certification was issued by A-lign, an independent and accredited certification body based in the United States on successful completion of a formal audit process.\n\n\nThis certification is evidence that Twist has met rigorous international standards in ensuring the confidentiality, integrity, and availability of its information security management system. This includes management of information security, privacy and compliance for internally developed and third-party applications and systems to sufficiently protect Twist intellectual property, customer intellectual property and other sensitive customer information.\n\n\n“We, at Twist Bioscience, are committed to the highest level of quality for all of our systems to keep our company and customer data private and secure,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “We have invested both financial and dedicated information technology resources to ensure that we continuously improve our security, with this certification validating our rigorous work against a total of 114 ISO 27001 security controls across our audited systems and infrastructure.”\n\n\nAbout Twist Bioscience Corporation\n\n\nTwist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing...